1-11 of 11
Clinical Trials and Observations
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Clinical Trials & Observations
Max J. Gordon, Sigrid Dubois, Milos D. Miljkovic, Samuel Ng, Bonita Bryant, Rahul Lakhotia, Christopher Melani, Stefania Pittaluga, Kevin Conlon, Thomas Waldmann, Louis M. Staudt, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (1): 100054.
https://doi.org/10.1016/j.bneo.2024.100054
Published: 2025
Journal Articles

JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study

Clinical Trials & Observations
Yu Uemura, Masahide Yamamoto, Masataka Ishimura, Hirokazu Kanegane, Akihisa Sawada, Akihiro Hirakawa, Ken-Ichi Imadome, Mayumi Yoshimori, Masashi Nagata, Kouhei Yamamoto, Norio Shimizu, Ryuji Koike, Ayako Arai
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (1): 100053.
https://doi.org/10.1016/j.bneo.2024.100053
Published: 2025
Includes: Supplemental data
Journal Articles

Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response

Clinical Trials & Observations
Naveen Pemmaraju, Tim C.P. Somervaille, Francesca Palandri, Claire Harrison, Rami S. Komrokji, Andrew Perkins, Rosa M. Ayala Diaz, David Lavie, Akihiro Tomita, Yang Feng, Qin Qin, Jason Harb, Akshanth R. Polepally, Jalaja Potluri, Jacqueline S. Garcia
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (1): 100056.
https://doi.org/10.1016/j.bneo.2024.100056
Published: 2025
Includes: Supplemental data
Journal Articles

Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma

Clinical Trials & Observations
Amrita Y. Krishnan, Krina K. Patel, Meera Mohan, Sundar Jagannath, Ruben Niesvizky, Rebecca W. Silbermann, Ziji Yu, Tao Long, Scott R. P. McDonnell, Deborah Berg, Keith E. Stockerl-Goldstein
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (4): 100043.
https://doi.org/10.1016/j.bneo.2024.100043
Published: 2024
Includes: Supplemental data
Journal Articles

A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy

Clinical Trials & Observations
Elizabeth A. Brem, Kevin Shieh, Dennis Juarez, Roberta Buono, Deepa Jeyakumar, Susan O’Brien, Thomas H. Taylor, David A. Fruman
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (4): 100036.
https://doi.org/10.1016/j.bneo.2024.100036
Published: 2024
Includes: Supplemental data
Journal Articles

Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium

Clinical Trials & Observations
Paul G. Kemps, F. J. Sherida H. Woei-A-Jin, Patrick Schöffski, Thomas Tousseyn, Isabelle Vanden Bempt, Friederike A. G. Meyer-Wentrup, Natasja Dors, Natasha K. A. van Eijkelenburg, Marijn A. Scheijde-Vermeulen, Ingrid M. Jazet, Maarten Limper, Margot Jak, Robert M. Verdijk, Marjolein L. Donker, Nick A. de Jonge, Carel J. M. van Noesel, Konnie M. Hebeda, Suzanne van Dorp, Sanne H. Tonino, Jan A. M. van Laar, Cor van den Bos, Astrid G. S. van Halteren
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (3): 100023.
https://doi.org/10.1016/j.bneo.2024.100023
Published: 2024
Includes: Supplemental data
Journal Articles

Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial

Clinical Trials & Observations
Ulrich Dührsen, Andreas Bockisch, Bernd Hertenstein, Imke E. Karsten, Frank Kroschinsky, Michael Heuser, Andreas Hochhaus, Heinz-Gert Höffkes, Dirk Behringer, Gabriele Prange-Krex, Mareike Tometten, Martin Grieshammer, Götz U. Grigoleit, Oliver Schmalz, Karin Jordan, Helga Bernhard, Tobias Gaska, Aristoteles Giagounidis, Roland Schroers, Uwe M. Martens, Gerhard Held, Wolfram Klapper, Karl-Heinz Jöckel, Michael Nonnemacher, Andreas Hüttmann
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (3): 100018.
https://doi.org/10.1016/j.bneo.2024.100018
Published: 2024
Includes: Supplemental data
Journal Articles

Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS

Clinical Trials & Observations
Jad Othman, Ho Pui Jeff Lam, Sarah Leong, Faisal Basheer, Islam Abdallah, Kathryn Fleming, Priyanka Mehta, Heba Yassin, John Laurie, Michael Austin, Paolo Gallipoli, Tom Taylor, Mike Dennis, Johnathon Elliot, Georgina Clarke, Raymond Dang, Jennifer Vidler, Pramila Krishnamurthy, Anne-Louise Latif, Pallavi Kalkur, Maryam Shahidianakbar, Victoria Campbell, Deepak Mannari, Emily Sutherland, Thishakya Wickramaratne, Angela Collins, Rui Zhao, Herng Mak, Edward Belsham, Shabnam Banerjee, Jamila Bashir, Srinivas Pillai, Richard Whitmill, Sofia Galli, Mariam Amer, Vidhya Murthy, Duncan Murray, Farooq Wandroo, Francesca Hogan, Francesca Crolla, Nicole Fowler, Anjum Khan, Jenny O’Nions, Richard Dillon
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (3): 100017.
https://doi.org/10.1016/j.bneo.2024.100017
Published: 2024
Includes: Supplemental data
Journal Articles

Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial

Clinical Trials & Observations
Timothy S. Pardee, Bayard L. Powell, Richard A. Larson, Joseph Maly, Michael Keng, Matthew Foster, Eun-Ji Choi, Heinz Sill, Thomas Cluzeau, Deepa Jeyakumar, Olga Frankfurt, Prapti Patel, Michael Schuster, Elisabeth Koller, Regis Costello, Uwe Platzbecker, Pau Montesinos, Susana Vives, Aziz Nazha, Rachel Cook, Carlos Vigil-Gonzales, Sylvain Chantepie, Sanjeev Luther, Jorge Cortes
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (2): 100009.
https://doi.org/10.1016/j.bneo.2024.100009
Published: 2024
Includes: Supplemental data
Journal Articles

Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination

Clinical Trials & Observations
Saishravan Shyamsundar, Sheila K. Pierson, Caoilfhionn M. Connolly, Mayan Teles, Dorry L. Segev, William A. Werbel, Frits van Rhee, Corey Casper, Joshua D. Brandstadter, Ariela Noy, David C. Fajgenbaum
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (1): 100002.
https://doi.org/10.1016/j.bneo.2024.100002
Published: 2024
Includes: Supplemental data
Journal Articles

KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational study

Clinical Trials & Observations
Hiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, Kensuke Usuki, Hideo Tanaka, Masaya Okada, Shugo Kowata, Kazunori Murai, Asao Hirose, Motohiro Shindo, Takashi Kumagai, Tomoharu Takeoka, Kazuharu Kamachi, Keisuke Kidoguchi, Takero Shindo, Satoshi Iyama, Junki Inamura, Takafumi Nakao, Tsutomu Kobayashi, Eri Kawata, Hiroshi Ohkawara, Takayuki Ikezoe, Atsushi Kawaguchi, Shinya Kimura
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (1): 100001.
https://doi.org/10.1016/j.bneo.2024.100001
Published: 2024
Includes: Supplemental data